Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free TLSIW Stock Alerts

TriSalus Life Sciences (TLSIW) Competitors

TriSalus Life Sciences logo
$0.71 -0.14 (-16.93%)
As of 02:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

TLSIW vs. DRTSW, ANZUW, HSCSW, BEATW, and LUCYW

Should you buy TriSalus Life Sciences stock or one of its competitors? MarketBeat compares TriSalus Life Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TriSalus Life Sciences include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry.

How does TriSalus Life Sciences compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
TriSalus Life Sciences$44.88MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

In the previous week, Alpha Tau Medical had 3 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 4 mentions for Alpha Tau Medical and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.39 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Neutral
TriSalus Life Sciences Very Positive

Summary

TriSalus Life Sciences beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Anzu Special Acquisition Corp I?

TriSalus Life Sciences (NASDAQ:TLSIW) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

In the previous week, TriSalus Life Sciences and TriSalus Life Sciences both had 1 articles in the media. TriSalus Life Sciences' average media sentiment score of 1.87 beat Anzu Special Acquisition Corp I's score of 0.87 indicating that TriSalus Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
TriSalus Life Sciences Very Positive
Anzu Special Acquisition Corp I Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Summary

TriSalus Life Sciences beats Anzu Special Acquisition Corp I on 2 of the 2 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Heart Test Laboratories?

TriSalus Life Sciences (NASDAQ:TLSIW) and Heart Test Laboratories (NASDAQ:HSCSW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
Heart Test Laboratories$8.67KN/AN/AN/AN/A

In the previous week, Heart Test Laboratories had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 2 mentions for Heart Test Laboratories and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.87 beat Heart Test Laboratories' score of 0.98 indicating that TriSalus Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
TriSalus Life Sciences Very Positive
Heart Test Laboratories Positive

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Heart Test Laboratories N/A N/A N/A

Summary

TriSalus Life Sciences beats Heart Test Laboratories on 2 of the 3 factors compared between the two stocks.

How does TriSalus Life Sciences compare to HeartBeam?

TriSalus Life Sciences (NASDAQ:TLSIW) and HeartBeam (NASDAQ:BEATW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

In the previous week, HeartBeam had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 2 mentions for HeartBeam and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.87 beat HeartBeam's score of 1.44 indicating that TriSalus Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
TriSalus Life Sciences Very Positive
HeartBeam Positive

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
HeartBeam N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$44.88MN/AN/AN/AN/A
HeartBeamN/AN/AN/AN/AN/A

Summary

TriSalus Life Sciences beats HeartBeam on 2 of the 3 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

In the previous week, Innovative Eyewear had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 2 mentions for Innovative Eyewear and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.87 beat Innovative Eyewear's score of 1.25 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Innovative Eyewear Positive
TriSalus Life Sciences Very Positive

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$2.98MN/AN/AN/AN/A
TriSalus Life Sciences$44.88MN/AN/AN/AN/A

Summary

TriSalus Life Sciences beats Innovative Eyewear on 2 of the 3 factors compared between the two stocks.

Get TriSalus Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLSIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLSIW vs. The Competition

Export
MetricTriSalus Life SciencesMedical Devices IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.10B$6.84B$12.44B
Dividend YieldN/A2.68%2.67%6.11%
P/E RatioN/A14.6225.8324.36
Price / SalesN/A126.85541.5496.87
Price / CashN/A15.9929.0936.93
Price / BookN/A4.4610.986.49
Net IncomeN/A$144.75M$3.57B$336.61M
7 Day Performance3.82%0.93%3.06%0.90%
1 Month Performance4.28%-0.91%0.72%-0.36%
1 Year PerformanceN/A0.38%36.82%31.26%

TriSalus Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLSIW
TriSalus Life Sciences
N/A$0.71
-16.9%		N/AN/A$0.00$44.88MN/A106
DRTSW
Alpha Tau Medical
N/A$2.04
+9.3%		N/A+793.6%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.05
flat		N/A-3.1%$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.06
+18.7%		N/A-11.6%$0.00$8.67KN/A10
BEATW
HeartBeam
N/A$0.04
-1.0%		N/A-92.0%$0.00N/AN/A5

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:TLSIW) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel